Cargando…

Successful Use of Intravenous Immunoglobulins in an Obinutuzumab-related Acute Thrombocytopenia

Detalles Bibliográficos
Autores principales:	Haage, Tobias R., Surov, Alexey, Mougiakakos, Dimitrios, Berisha, Mirjeta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351898/ https://www.ncbi.nlm.nih.gov/pubmed/35935607 http://dx.doi.org/10.1097/HS9.0000000000000751

Ejemplares similares

Use of obinutuzumab for refractory autoimmune thrombocytopenia secondary to CLL
por: Agrawal, Rohitashva, et al.
Publicado: (2020)

Membranous nephropathy associated with immunoglobulin G4-related disease successfully treated with obinutuzumab
por: Ginthör, Noemi E, et al.
Publicado: (2021)

PD-L1/PD-1: new kid on the “immune metabolic” block
por: Qorraj, Mirjeta, et al.
Publicado: (2017)

Successful treatment of hairy cell leukemia variant with obinutuzumab
por: Al-Sarayfi, Diana, et al.
Publicado: (2021)

How ITD Insertion Sites Orchestrate the Biology and Disease of FLT3-ITD-Mutated Acute Myeloid Leukemia
por: Haage, Tobias R., et al.
Publicado: (2023)

Acute syndrome of apoptotic pan-epidermolysis successfully treated with intravenous immunoglobulin and steroid combination
por: Şentürk, Nilgun, et al.
Publicado: (2022)

Secondary Immune Thrombocytopenia Associated With Asymptomatic COVID-19 Successfully Managed With Intravenous Immunoglobulin and Glucocorticoids
por: Ayesh, Hazem, et al.
Publicado: (2021)

Intravenous immunoglobulins for treatment of severe COVID-19-related acute encephalopathy
por: Huo, Shufan, et al.
Publicado: (2022)

Successful obinutuzumab administration after rituximab discontinuation due to intolerance in patients with hematologic disorders
por: Schieber, Timothy, et al.
Publicado: (2023)

Genetic Knock-out of TNFR1 and TNFR2 in a JAK2-V617F Polycythemia Vera Mouse Model
por: Müller, Peter, et al.
Publicado: (2022)

Obinutuzumab is Effective for the Treatment of Refractory Membranous Nephropathy
por: Sethi, Supreet, et al.
Publicado: (2020)

Obinutuzumab Rescue in Rituximab Resistant Mixed Cryoglobulinemia
por: Genest, Dominique S., et al.
Publicado: (2021)

The use of IV immunoglobulin in the treatment of vaccine-induced immune thrombotic thrombocytopenia
por: Uzun, Günalp, et al.
Publicado: (2021)

Obinutuzumab in Allogeneic Transplantation for CLL and Richter’s Transformation in the Age of Targeted Therapies
por: Pflug, Natali, et al.
Publicado: (2021)

Is It Safe to Switch From Intravenous Immunoglobulin to Subcutaneous Immunoglobulin in Patients With Common Variable Immunodeficiency and Autoimmune Thrombocytopenia?
por: Scheuerlein, Philipp, et al.
Publicado: (2018)

Successful Use of Intravenous Immunoglobulin G to Treat Refractory Heparin-Induced Thrombocytopenia With Thrombosis Complicating Peripheral Blood Stem Cell Harvest
por: McKenzie, Devon S., et al.
Publicado: (2018)

Entospletinib and obinutuzumab in patients with relapsed/refractory chronic lymphocytic leukemia and B-cell malignancies
por: Kittai, Adam S., et al.
Publicado: (2021)

Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia
por: Sharman, Jeff P., et al.
Publicado: (2022)

Antiplatelet Antibodies Do Not Predict the Response to Intravenous Immunoglobulins during Immune Thrombocytopenia
por: Rogier, Thomas, et al.
Publicado: (2020)

Efficacy and safety of a new intravenous immunoglobulin (Panzyga(®)) in chronic immune thrombocytopenia
por: Arbach, O., et al.
Publicado: (2019)

Early Utilization of Intravenous Immunoglobulin in Heparin-Induced Thrombocytopenia for Limb Salvaging Purposes
por: Abu Kar, Sarah, et al.
Publicado: (2022)

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia
por: Kaur, Manraj N., et al.
Publicado: (2022)

Efficacy and Safety of Tirabrutinib and Idelalisib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia
por: Kutsch, Nadine, et al.
Publicado: (2022)

Autoimmune Heparin-Induced Thrombocytopenia after Transcatheter Aortic Valve Implantation: Successful Treatment with Adjunct High-Dose Intravenous Immunoglobulin
por: Bakchoul, Tamam, et al.
Publicado: (2019)

Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study
por: Fresa, Alberto, et al.
Publicado: (2022)

Treatment of West Nile virus encephalitis with intravenous immunoglobulin.
por: Shimoni, Z, et al.
Publicado: (2001)

Tigecycline as salvage treatment of febrile neutropenia in patients with haematological malignancies—a retrospective single-centre analysis of 200 cases
por: Geßner, Daniel, et al.
Publicado: (2023)

May early intervention with intravenous immunoglobulin pose a potentially successful treatment for Ebola virus infection?
por: Ge, Ying, et al.
Publicado: (2014)

Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia
por: Kutsch, Nadine, et al.
Publicado: (2022)

Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab
por: Balasubramanian, S., et al.
Publicado: (2020)

Coxsackievirus A16 Encephalitis during Obinutuzumab Therapy, Belgium, 2013
por: Eyckmans, Tom, et al.
Publicado: (2014)

Prioritization of Evidence-Based Indications for Intravenous Immunoglobulin
por: Orange, Jordan S., et al.
Publicado: (2013)

Periorbital Necrobiotic Xanthogranuloma Successfully Treated with Intravenous Immunoglobulin
por: Olson, Rose M., et al.
Publicado: (2018)

Adult Krabbe Disease That Was Successfully Treated with Intravenous Immunoglobulin
por: Fukazawa, Ryosuke, et al.
Publicado: (2020)

Obinutuzumab in connective tissue diseases after former rituximab-non-response: a case series
por: Kvacskay, Peter, et al.
Publicado: (2022)

Intravenous immunoglobulins in infantile dyshidrosiform bullous pemphigoid refractory to steroids and dapsone
por: Viglizzo, Gianmaria, et al.
Publicado: (2022)

Intravenous Immunoglobulin (IVIg) Utilization in Immune Thrombocytopenia (ITP): A Multi-Center, Retrospective Review
por: Hsia, Cyrus C., et al.
Publicado: (2015)

Effect of intravenous immunoglobulin therapy on the prognosis of patients with severe fever with thrombocytopenia syndrome and neurological complications
por: Liu, Yun, et al.
Publicado: (2023)

Toxic epidermal necrolysis in an 8-year-old girl successfully treated with cyclosporin A, intravenous immunoglobulin and plasma exchange
por: Zielińska, Marzena, et al.
Publicado: (2018)

Intravenous immunoglobulin: A potential treatment for the post-acute sequelae of SARS-Cov-2 infection?
por: Reznik, Sandra E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ov915gdv2j28l6pkhiicamev63